Healthscope (ASX:HSO) Investments And Advances : A$9 Mil (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Healthscope Investments And Advances?

Healthscope's Investments And Advances for the quarter that ended in Dec. 2018 was A$9 Mil.

Healthscope's quarterly Investments And Advances increased from Dec. 2017 (A$9 Mil) to Jun. 2018 (A$9 Mil) but then declined from Jun. 2018 (A$9 Mil) to Dec. 2018 (A$9 Mil).

Healthscope's annual Investments And Advances declined from Jun. 2016 (A$10 Mil) to Jun. 2017 (A$9 Mil) but then increased from Jun. 2017 (A$9 Mil) to Jun. 2018 (A$9 Mil).

Healthscope Investments And Advances Historical Data

The historical data trend for Healthscope's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthscope Investments And Advances Chart

Healthscope Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Investments And Advances

3.57

9.50

9.00

9.40

Healthscope Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Investments And Advances	Get a 7-Day Free Trial				9.20	9.00	8.90	9.40	9.00

Healthscope Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Healthscope (ASX:HSO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Healthscope Ltd (ASX:HSO) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

N/A

Address

312 St Kilda Road, Level 1, Melbourne, VIC, AUS, 3004

Website

http://www.healthscope.com.au

Healthscope is the second-largest provider of private hospital services in Australia and a leading provider of pathology services in Australia, New Zealand, Malaysia, and Singapore. At a service level, the private hospital portfolio comprises 31 acute hospitals, seven psychiatric hospitals, and six rehabilitation and extended-care facilities, which are concentrated within the three major population centres of Sydney, Melbourne, and Brisbane on the east coast of Australia.

Healthscope (ASX:HSO) Headlines

No Headlines